For new biotechnology firms with or without in-house statistical capabilities, we provide consultation on the design and analysis of Phase 1 through Phase 3 trials. Clients utilize our guidance and statistical expertise in preparing protocols for clinical trials. We consult with scientists and clinicians on the development of drugs— and as young companies grow, we help them find new staff statisticians.